Review



phospho pi3k p pi3k  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Bioss phospho pi3k p pi3k
    (A) (B) Western blot of autophagy-related proteins. (C) Western blot of <t>PI3K/AKT/mTOR</t> pathway proteins. (D–J) Quantitative analysis of (D) Beclin-1, (E) Atg5, (F) LC3II/I, (G) P62, (H) <t>p-PI3K/PI3K,</t> (I) p-AKT/AKT, and (J) p-mTOR/mTOR protein levels. Data are mean ± SEM; #P < 0.05, ##P < 0.01 vs Control; *P < 0.05, **P < 0.01 vs DSS group.
    Phospho Pi3k P Pi3k, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 55 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phospho pi3k p pi3k/product/Bioss
    Average 95 stars, based on 55 article reviews
    phospho pi3k p pi3k - by Bioz Stars, 2026-02
    95/100 stars

    Images

    1) Product Images from "Butyrate ameliorates DSS-induced ulcerative colitis in mice by facilitating autophagy in intestinal epithelial cells and modulating the gut microbiota through blocking the PI3K-AKT-mTOR pathway"

    Article Title: Butyrate ameliorates DSS-induced ulcerative colitis in mice by facilitating autophagy in intestinal epithelial cells and modulating the gut microbiota through blocking the PI3K-AKT-mTOR pathway

    Journal: PLOS One

    doi: 10.1371/journal.pone.0337214

    (A) (B) Western blot of autophagy-related proteins. (C) Western blot of PI3K/AKT/mTOR pathway proteins. (D–J) Quantitative analysis of (D) Beclin-1, (E) Atg5, (F) LC3II/I, (G) P62, (H) p-PI3K/PI3K, (I) p-AKT/AKT, and (J) p-mTOR/mTOR protein levels. Data are mean ± SEM; #P < 0.05, ##P < 0.01 vs Control; *P < 0.05, **P < 0.01 vs DSS group.
    Figure Legend Snippet: (A) (B) Western blot of autophagy-related proteins. (C) Western blot of PI3K/AKT/mTOR pathway proteins. (D–J) Quantitative analysis of (D) Beclin-1, (E) Atg5, (F) LC3II/I, (G) P62, (H) p-PI3K/PI3K, (I) p-AKT/AKT, and (J) p-mTOR/mTOR protein levels. Data are mean ± SEM; #P < 0.05, ##P < 0.01 vs Control; *P < 0.05, **P < 0.01 vs DSS group.

    Techniques Used: Western Blot, Control



    Similar Products

    95
    Bioss phospho pi3k p pi3k
    (A) (B) Western blot of autophagy-related proteins. (C) Western blot of <t>PI3K/AKT/mTOR</t> pathway proteins. (D–J) Quantitative analysis of (D) Beclin-1, (E) Atg5, (F) LC3II/I, (G) P62, (H) <t>p-PI3K/PI3K,</t> (I) p-AKT/AKT, and (J) p-mTOR/mTOR protein levels. Data are mean ± SEM; #P < 0.05, ##P < 0.01 vs Control; *P < 0.05, **P < 0.01 vs DSS group.
    Phospho Pi3k P Pi3k, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phospho pi3k p pi3k/product/Bioss
    Average 95 stars, based on 1 article reviews
    phospho pi3k p pi3k - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    93
    MedChemExpress ratio p pi3k hy p81211
    (A) (B) Western blot of autophagy-related proteins. (C) Western blot of <t>PI3K/AKT/mTOR</t> pathway proteins. (D–J) Quantitative analysis of (D) Beclin-1, (E) Atg5, (F) LC3II/I, (G) P62, (H) <t>p-PI3K/PI3K,</t> (I) p-AKT/AKT, and (J) p-mTOR/mTOR protein levels. Data are mean ± SEM; #P < 0.05, ##P < 0.01 vs Control; *P < 0.05, **P < 0.01 vs DSS group.
    Ratio P Pi3k Hy P81211, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ratio p pi3k hy p81211/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    ratio p pi3k hy p81211 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress p pi3k mce hy p81211
    (A) (B) Western blot of autophagy-related proteins. (C) Western blot of <t>PI3K/AKT/mTOR</t> pathway proteins. (D–J) Quantitative analysis of (D) Beclin-1, (E) Atg5, (F) LC3II/I, (G) P62, (H) <t>p-PI3K/PI3K,</t> (I) p-AKT/AKT, and (J) p-mTOR/mTOR protein levels. Data are mean ± SEM; #P < 0.05, ##P < 0.01 vs Control; *P < 0.05, **P < 0.01 vs DSS group.
    P Pi3k Mce Hy P81211, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p pi3k mce hy p81211/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    p pi3k mce hy p81211 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress p pi3k antibody
    (A) (B) Western blot of autophagy-related proteins. (C) Western blot of <t>PI3K/AKT/mTOR</t> pathway proteins. (D–J) Quantitative analysis of (D) Beclin-1, (E) Atg5, (F) LC3II/I, (G) P62, (H) <t>p-PI3K/PI3K,</t> (I) p-AKT/AKT, and (J) p-mTOR/mTOR protein levels. Data are mean ± SEM; #P < 0.05, ##P < 0.01 vs Control; *P < 0.05, **P < 0.01 vs DSS group.
    P Pi3k Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p pi3k antibody/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    p pi3k antibody - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc p pi3k
    Therapeutic mechanism of PX-TA-AmB in FK via <t>MAPK6/PI3K/AKT</t> pathway modulation. (A) Volcano plot of the differentially expressed genes. (B) KEGG pathway enrichment analysis of the differentially expressed genes. (C) Heatmap of the differentially expressed genes related to the inflammatory response, signaling pathway regulation, and corneal scarring before and after PX-TA-AmB treatment. (D, E) GSEA with the indicated KEGG and Reactome gene sets. (F, G, H) MAPK6, α-SMA, and LOX mRNA expression levels in treated versus control corneal tissues. (I) Representative Western blot images of p-AKT, AKT, p-PI3K, PI3K, MAPK6, Vinculin, and β-actin proteins in different treatment groups. (J) Representative Western blot images of IL-1β and MMP9 in different treatment groups. (K) Representative Western blot images for functional validation of the role of AKT pathway in PX-TA-AmB-mediated downregulation of IL-1β and MMP9 using the AKT activator SC79. (L) Immunofluorescence assessment of α-SMA, MMP9, CD206, CD86, and Ly6G under different treatments. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. Mean ± SD, n = 3; one-way ANOVA.
    P Pi3k, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p pi3k/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    p pi3k - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc co ip p pi3k cell signaling technology 17366s
    Therapeutic mechanism of PX-TA-AmB in FK via <t>MAPK6/PI3K/AKT</t> pathway modulation. (A) Volcano plot of the differentially expressed genes. (B) KEGG pathway enrichment analysis of the differentially expressed genes. (C) Heatmap of the differentially expressed genes related to the inflammatory response, signaling pathway regulation, and corneal scarring before and after PX-TA-AmB treatment. (D, E) GSEA with the indicated KEGG and Reactome gene sets. (F, G, H) MAPK6, α-SMA, and LOX mRNA expression levels in treated versus control corneal tissues. (I) Representative Western blot images of p-AKT, AKT, p-PI3K, PI3K, MAPK6, Vinculin, and β-actin proteins in different treatment groups. (J) Representative Western blot images of IL-1β and MMP9 in different treatment groups. (K) Representative Western blot images for functional validation of the role of AKT pathway in PX-TA-AmB-mediated downregulation of IL-1β and MMP9 using the AKT activator SC79. (L) Immunofluorescence assessment of α-SMA, MMP9, CD206, CD86, and Ly6G under different treatments. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. Mean ± SD, n = 3; one-way ANOVA.
    Co Ip P Pi3k Cell Signaling Technology 17366s, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/co ip p pi3k cell signaling technology 17366s/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    co ip p pi3k cell signaling technology 17366s - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc phospho-phosphoinositide-3-kinase (p-pi3k) antibody
    Therapeutic mechanism of PX-TA-AmB in FK via <t>MAPK6/PI3K/AKT</t> pathway modulation. (A) Volcano plot of the differentially expressed genes. (B) KEGG pathway enrichment analysis of the differentially expressed genes. (C) Heatmap of the differentially expressed genes related to the inflammatory response, signaling pathway regulation, and corneal scarring before and after PX-TA-AmB treatment. (D, E) GSEA with the indicated KEGG and Reactome gene sets. (F, G, H) MAPK6, α-SMA, and LOX mRNA expression levels in treated versus control corneal tissues. (I) Representative Western blot images of p-AKT, AKT, p-PI3K, PI3K, MAPK6, Vinculin, and β-actin proteins in different treatment groups. (J) Representative Western blot images of IL-1β and MMP9 in different treatment groups. (K) Representative Western blot images for functional validation of the role of AKT pathway in PX-TA-AmB-mediated downregulation of IL-1β and MMP9 using the AKT activator SC79. (L) Immunofluorescence assessment of α-SMA, MMP9, CD206, CD86, and Ly6G under different treatments. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. Mean ± SD, n = 3; one-way ANOVA.
    Phospho Phosphoinositide 3 Kinase (P Pi3k) Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phospho-phosphoinositide-3-kinase (p-pi3k) antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    phospho-phosphoinositide-3-kinase (p-pi3k) antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc anti-phospho-pi3k (p-pi3k) antibodies
    MβCD increases <t>PI3K</t> phosphorylation, while inhibition of S1PR or NOS impairs MβCD-induced tyrosine phosphorylation. Spermatozoa were incubated for 3.5 h at 37 °C under various conditions: untreated (−), treated with 10 % v/v fetal cord serum ultrafiltrate (FCSu), treated with 0.5 mM methyl-β-cyclodextrin (MβCD), and treated with MβCD in combination with ( a ) 40 μM VPC 23019 (S1PR1/3 inhibitor) or ( b ) l -NAME (Nitric Oxide Synthase inhibitor). ( a ) Immunoblotting analysis revealed that VPC 23019 at 40 μM decreased PI3K phosphorylation <t>(P-PI3K)</t> in spermatozoa incubated with 0.5 mM of MβCD. ( b ) Immunoblotting showed that l -NAME treatment decreased tyrosine phosphorylation (P-Tyr) in sperm samples treated with FCSu and MβCD. The signal intensity for each lane was normalized to the silver-stain optical density value for accurate quantification. α-Tubulin loading controls were performed for direct comparison with the silver stain loading controls. The data represent sperm samples from four different healthy donors (n = 4). Statistical analysis was performed using ANOVA with Tukey's test: ∗p ≤ 0.05, ∗∗p ≤ 0.01, and ∗∗∗p ≤ 0.001.
    Anti Phospho Pi3k (P Pi3k) Antibodies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-phospho-pi3k (p-pi3k) antibodies/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    anti-phospho-pi3k (p-pi3k) antibodies - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    MyBiosource Biotechnology phosphorylated phosphoinositide 3-kinase (p-pi3k) (phospho-tyr607)
    MβCD increases <t>PI3K</t> phosphorylation, while inhibition of S1PR or NOS impairs MβCD-induced tyrosine phosphorylation. Spermatozoa were incubated for 3.5 h at 37 °C under various conditions: untreated (−), treated with 10 % v/v fetal cord serum ultrafiltrate (FCSu), treated with 0.5 mM methyl-β-cyclodextrin (MβCD), and treated with MβCD in combination with ( a ) 40 μM VPC 23019 (S1PR1/3 inhibitor) or ( b ) l -NAME (Nitric Oxide Synthase inhibitor). ( a ) Immunoblotting analysis revealed that VPC 23019 at 40 μM decreased PI3K phosphorylation <t>(P-PI3K)</t> in spermatozoa incubated with 0.5 mM of MβCD. ( b ) Immunoblotting showed that l -NAME treatment decreased tyrosine phosphorylation (P-Tyr) in sperm samples treated with FCSu and MβCD. The signal intensity for each lane was normalized to the silver-stain optical density value for accurate quantification. α-Tubulin loading controls were performed for direct comparison with the silver stain loading controls. The data represent sperm samples from four different healthy donors (n = 4). Statistical analysis was performed using ANOVA with Tukey's test: ∗p ≤ 0.05, ∗∗p ≤ 0.01, and ∗∗∗p ≤ 0.001.
    Phosphorylated Phosphoinositide 3 Kinase (P Pi3k) (Phospho Tyr607), supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated phosphoinositide 3-kinase (p-pi3k) (phospho-tyr607)/product/MyBiosource Biotechnology
    Average 90 stars, based on 1 article reviews
    phosphorylated phosphoinositide 3-kinase (p-pi3k) (phospho-tyr607) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    96
    Proteintech pi3k akt p akt egfr bax bcl 2 vimentin β actin 150 gapdh
    MβCD increases <t>PI3K</t> phosphorylation, while inhibition of S1PR or NOS impairs MβCD-induced tyrosine phosphorylation. Spermatozoa were incubated for 3.5 h at 37 °C under various conditions: untreated (−), treated with 10 % v/v fetal cord serum ultrafiltrate (FCSu), treated with 0.5 mM methyl-β-cyclodextrin (MβCD), and treated with MβCD in combination with ( a ) 40 μM VPC 23019 (S1PR1/3 inhibitor) or ( b ) l -NAME (Nitric Oxide Synthase inhibitor). ( a ) Immunoblotting analysis revealed that VPC 23019 at 40 μM decreased PI3K phosphorylation <t>(P-PI3K)</t> in spermatozoa incubated with 0.5 mM of MβCD. ( b ) Immunoblotting showed that l -NAME treatment decreased tyrosine phosphorylation (P-Tyr) in sperm samples treated with FCSu and MβCD. The signal intensity for each lane was normalized to the silver-stain optical density value for accurate quantification. α-Tubulin loading controls were performed for direct comparison with the silver stain loading controls. The data represent sperm samples from four different healthy donors (n = 4). Statistical analysis was performed using ANOVA with Tukey's test: ∗p ≤ 0.05, ∗∗p ≤ 0.01, and ∗∗∗p ≤ 0.001.
    Pi3k Akt P Akt Egfr Bax Bcl 2 Vimentin β Actin 150 Gapdh, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pi3k akt p akt egfr bax bcl 2 vimentin β actin 150 gapdh/product/Proteintech
    Average 96 stars, based on 1 article reviews
    pi3k akt p akt egfr bax bcl 2 vimentin β actin 150 gapdh - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    Image Search Results


    (A) (B) Western blot of autophagy-related proteins. (C) Western blot of PI3K/AKT/mTOR pathway proteins. (D–J) Quantitative analysis of (D) Beclin-1, (E) Atg5, (F) LC3II/I, (G) P62, (H) p-PI3K/PI3K, (I) p-AKT/AKT, and (J) p-mTOR/mTOR protein levels. Data are mean ± SEM; #P < 0.05, ##P < 0.01 vs Control; *P < 0.05, **P < 0.01 vs DSS group.

    Journal: PLOS One

    Article Title: Butyrate ameliorates DSS-induced ulcerative colitis in mice by facilitating autophagy in intestinal epithelial cells and modulating the gut microbiota through blocking the PI3K-AKT-mTOR pathway

    doi: 10.1371/journal.pone.0337214

    Figure Lengend Snippet: (A) (B) Western blot of autophagy-related proteins. (C) Western blot of PI3K/AKT/mTOR pathway proteins. (D–J) Quantitative analysis of (D) Beclin-1, (E) Atg5, (F) LC3II/I, (G) P62, (H) p-PI3K/PI3K, (I) p-AKT/AKT, and (J) p-mTOR/mTOR protein levels. Data are mean ± SEM; #P < 0.05, ##P < 0.01 vs Control; *P < 0.05, **P < 0.01 vs DSS group.

    Article Snippet: PI3K, P62, and Beclin-1 antibodies were obtained from ABclonal (A19742, A19700, and A21191, Wuhan, China), and phospho-PI3K (p-PI3K) from Bioss (bs-5570R, Beijing, China).

    Techniques: Western Blot, Control

    Therapeutic mechanism of PX-TA-AmB in FK via MAPK6/PI3K/AKT pathway modulation. (A) Volcano plot of the differentially expressed genes. (B) KEGG pathway enrichment analysis of the differentially expressed genes. (C) Heatmap of the differentially expressed genes related to the inflammatory response, signaling pathway regulation, and corneal scarring before and after PX-TA-AmB treatment. (D, E) GSEA with the indicated KEGG and Reactome gene sets. (F, G, H) MAPK6, α-SMA, and LOX mRNA expression levels in treated versus control corneal tissues. (I) Representative Western blot images of p-AKT, AKT, p-PI3K, PI3K, MAPK6, Vinculin, and β-actin proteins in different treatment groups. (J) Representative Western blot images of IL-1β and MMP9 in different treatment groups. (K) Representative Western blot images for functional validation of the role of AKT pathway in PX-TA-AmB-mediated downregulation of IL-1β and MMP9 using the AKT activator SC79. (L) Immunofluorescence assessment of α-SMA, MMP9, CD206, CD86, and Ly6G under different treatments. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. Mean ± SD, n = 3; one-way ANOVA.

    Journal: Bioactive Materials

    Article Title: Pathology-inspired collagen-binding thermosensitive micelle drops enable prolonged and efficient treatment of fungal keratitis

    doi: 10.1016/j.bioactmat.2025.04.011

    Figure Lengend Snippet: Therapeutic mechanism of PX-TA-AmB in FK via MAPK6/PI3K/AKT pathway modulation. (A) Volcano plot of the differentially expressed genes. (B) KEGG pathway enrichment analysis of the differentially expressed genes. (C) Heatmap of the differentially expressed genes related to the inflammatory response, signaling pathway regulation, and corneal scarring before and after PX-TA-AmB treatment. (D, E) GSEA with the indicated KEGG and Reactome gene sets. (F, G, H) MAPK6, α-SMA, and LOX mRNA expression levels in treated versus control corneal tissues. (I) Representative Western blot images of p-AKT, AKT, p-PI3K, PI3K, MAPK6, Vinculin, and β-actin proteins in different treatment groups. (J) Representative Western blot images of IL-1β and MMP9 in different treatment groups. (K) Representative Western blot images for functional validation of the role of AKT pathway in PX-TA-AmB-mediated downregulation of IL-1β and MMP9 using the AKT activator SC79. (L) Immunofluorescence assessment of α-SMA, MMP9, CD206, CD86, and Ly6G under different treatments. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. Mean ± SD, n = 3; one-way ANOVA.

    Article Snippet: The total protein was separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto a 0.45 μm pore size polyvinylidene fluoride (PVDF) membrane (Millipore, Germany); this membrane was then blocked with 5 % milk at room temperature and incubated with primary antibodies overnight at 4 °C; these antibodies included p-PI3K (Cell Signaling Technology, 4228, 1:1000), PI3K (Cell Signaling Technology, 4257, 1:1000), p-Akt (ABclonal, AP1453, 1:1000), Akt (ABclonal, A18675, 1:2000), MAPK6 (Abcam, ab53277, 1:1000), IL-1β (Abcam, ab9722, 1:1000), MMP9 (Proteintech, 10375-2-AP, 1:1000), Vinculin (Proteintech, 26520-1-AP, 1:10000) and β-Actin (ABclonal, AC026, 1:20000).

    Techniques: Expressing, Control, Western Blot, Functional Assay, Biomarker Discovery, Immunofluorescence

    MβCD increases PI3K phosphorylation, while inhibition of S1PR or NOS impairs MβCD-induced tyrosine phosphorylation. Spermatozoa were incubated for 3.5 h at 37 °C under various conditions: untreated (−), treated with 10 % v/v fetal cord serum ultrafiltrate (FCSu), treated with 0.5 mM methyl-β-cyclodextrin (MβCD), and treated with MβCD in combination with ( a ) 40 μM VPC 23019 (S1PR1/3 inhibitor) or ( b ) l -NAME (Nitric Oxide Synthase inhibitor). ( a ) Immunoblotting analysis revealed that VPC 23019 at 40 μM decreased PI3K phosphorylation (P-PI3K) in spermatozoa incubated with 0.5 mM of MβCD. ( b ) Immunoblotting showed that l -NAME treatment decreased tyrosine phosphorylation (P-Tyr) in sperm samples treated with FCSu and MβCD. The signal intensity for each lane was normalized to the silver-stain optical density value for accurate quantification. α-Tubulin loading controls were performed for direct comparison with the silver stain loading controls. The data represent sperm samples from four different healthy donors (n = 4). Statistical analysis was performed using ANOVA with Tukey's test: ∗p ≤ 0.05, ∗∗p ≤ 0.01, and ∗∗∗p ≤ 0.001.

    Journal: Redox Biology

    Article Title: Dysregulation of sphingolipid and cholesterol homeostasis imposes oxidative stress in human spermatozoa

    doi: 10.1016/j.redox.2025.103669

    Figure Lengend Snippet: MβCD increases PI3K phosphorylation, while inhibition of S1PR or NOS impairs MβCD-induced tyrosine phosphorylation. Spermatozoa were incubated for 3.5 h at 37 °C under various conditions: untreated (−), treated with 10 % v/v fetal cord serum ultrafiltrate (FCSu), treated with 0.5 mM methyl-β-cyclodextrin (MβCD), and treated with MβCD in combination with ( a ) 40 μM VPC 23019 (S1PR1/3 inhibitor) or ( b ) l -NAME (Nitric Oxide Synthase inhibitor). ( a ) Immunoblotting analysis revealed that VPC 23019 at 40 μM decreased PI3K phosphorylation (P-PI3K) in spermatozoa incubated with 0.5 mM of MβCD. ( b ) Immunoblotting showed that l -NAME treatment decreased tyrosine phosphorylation (P-Tyr) in sperm samples treated with FCSu and MβCD. The signal intensity for each lane was normalized to the silver-stain optical density value for accurate quantification. α-Tubulin loading controls were performed for direct comparison with the silver stain loading controls. The data represent sperm samples from four different healthy donors (n = 4). Statistical analysis was performed using ANOVA with Tukey's test: ∗p ≤ 0.05, ∗∗p ≤ 0.01, and ∗∗∗p ≤ 0.001.

    Article Snippet: Rabbit polyclonal anti-phospho-PI3K (P-PI3K) antibodies were purchased from Cell Signaling ( # 4228) (Beverly, MA, USA).

    Techniques: Phospho-proteomics, Inhibition, Incubation, Western Blot, Silver Staining, Comparison